Skip to main content
OpenTrials
Completed

NCT Number: NCT03559595

Increasing PrEP Among African Americans in Louisville KY

This study evaluates the effectiveness of a multifaceted strategy to increase pre-exposure prophylaxis (PrEP; a medication regimen to reduce HIV risk) uptake among high risk African Americans in Louisville, KY. We will do this by 1) implementing a media campaign to raise awareness about PrEP, 2) providing PrEP education to medical personnel who can prescribe PrEP, and 3) partnering with AIDS service organizations to improve outreach and linkage to PrEP services.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV/AIDS Prevention

Age range

18 year–29 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Louisville

Louisville, Kentucky, 40202, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Between ages 18-29 years old
  • Self-identifies as African American or Black
  • Resident of Louisville, KY
  • Member of a priority group for PrEP HIV prevention (Men who have sex with men, people who inject drugs, trans women, high risk heterosexuals, people in serodiscordant relationships).
  • Not diagnosed with HIV

Exclusion criteria

  • Older than 29 and younger than 18 years old
  • Does not identify as African American or Black
  • Does not reside in Louisville, KY
  • Not a member of a priority group
  • Diagnosed with HIV

Treatment and study plan

Project Prevent

Behavioral

The Project Prevent intervention entails 1) a media campaign to raise PrEP awareness, 2) geographically targeted education initiatives with medical personnel to increase access to consumers, and 3) programming with AIDS service organizations to improve service delivery around PrEP.

Primary outcomes

  1. PrEP uptake

    Time frame: 12 months

    Reported use of PrEP

Secondary outcomes

  1. PrEP intentions

    Time frame: 12 months

    Intention to use PrEP

  2. PrEP prescription

    Time frame: 12 months

    Prescription of PrEP to eligible individuals by medical personnel

Sponsors and collaborators

Lead sponsor

University of Louisville

Other

Registry information

Official study title

Increasing Pre-exposure Prophylaxis Among High-Risk African Americans in Louisville KY

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
Jun 18, 2018
Registry last updated
Mar 29, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.